March 2026

Glenmark Specialty SA has received final approval from the U.S. Food and Drug Administration for Fluticasone Propionate Inhalation Aerosol USP

The regulator has announced that companies will now receive the No Objection Certificate, NOC more quickly, helping to streamline regulatory procedures and reduce approval timelines.

D.Pharm plus two Years experience in relevant subject/field. Managing Ocular Surface Disorders, Randomized Trials on Dry Eye Disease and Meibomian Gland Dysfunction

M.Sc /M. Tech. in Life Sciences or related natural science disciplines. Lethal Aortopathy syndrome associated with novel FBLN4D203A Mutation among Mappila Children of Malabar, Kerala - seeking novel clinical, molecular genetic and anthropological insights.

M.Pharm in Pharmaceutics / Pharmacology or any other equivalent Degree. Previous research/industry experience in exosome formulation and development, animal handling skills.

Post-graduate degree (M.Sc./MS) in Life Sciences, Clinical Chemistry ; M.Tech. in Biomedical Engineering/ Bioengineering/ Biotechnology/ Medical Devices.

B.Pharm or D.Pharm from a recognized university. Registered with Indian Nursing council or Pharmacist Council of India with 2 years of experience post qualification. All India Institute of Medical Sciences (AIIMS) Bhopal

M.Tech./M.Pharm./MBA/M.Phil. or M.Sc./B.Pharm. or an equivalent degree with a minimum of 60 percent aggregate in the qualifying examination

A Diploma in Pharmacy or Bachelor of Pharmacy or Pharm.D. District Health Society of Chengalpattu